Paladin Labs has launched Silenor (doxepin hydrochloride), specified for the treatment and symptomatic relief of insomnia with characteristics of frequent nocturnal awakening and/or early morning awakenings, in Canada. Silenor, which is ...
Canada-based Paladin Labs has introduced a self diagnostic test, designed for the detection of bacterial vaginosis and trichomoniasis, in Canada. The VagiSense test, which the company claims to be the Canada''s only over-the-counter ...
Tags: Paladin Labs, self diagnostic test, bacterial vaginosis, trichomoniasis
Paladin Labs, Somaxon Pharmaceuticals' licensee, has obtained Health Canada approval for Silenor new drug submission. Silenor, a low-dose doxepin oral tablet formulation, is developed to treat insomnia and symptoms such as frequent ...
Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet,Oralair,against grass pollen allergies in Canada. The sublingual once daily medication should be administered from four months prior to the ...
Tags: grass pollen allergy, Paladin Labs, allergen immunotherapy tablet